COSCIENS Biopharma (CSCI)
NASDAQ:CSCI
Holding CSCI?
Track your performance easily

COSCIENS Biopharma (CSCI) Technical Analysis

905 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
6Neutral
11Bearish
Technical Analysis Consensus
Sell
1Bullish
6Neutral
3Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
COSCIENS Biopharma’s (CSCI) Moving Averages Convergence Divergence (MACD) indicator is -0.37, suggesting COSCIENS Biopharma is a Sell.
COSCIENS Biopharma’s (CSCI) 20-Day exponential moving average is 4.44, while COSCIENS Biopharma’s (CSCI) share price is $4.145, making it a Sell.
COSCIENS Biopharma’s (CSCI) 50-Day exponential moving average is 5.11, while COSCIENS Biopharma’s (CSCI) share price is $4.145, making it a Sell.

COSCIENS Biopharma (CSCI) Pivot Points

Sep 20, 2024, 12:19 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
4.10
4.10
4.10
4.10
4.10
4.10
4.10
Fibonacci
4.10
4.10
4.10
4.10
4.10
4.10
4.10
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

COSCIENS Biopharma (CSCI) Moving Averages

Sep 20, 2024, 12:19 AM
Period
Simple
Exponential
MA5
4.15Buy
4.16Buy
MA10
4.10Buy
4.19Buy
MA20
4.42Sell
4.44Sell
MA50
5.29Sell
5.11Sell
MA100
6.22Sell
5.85Sell
MA200
7.05Sell
6.64Sell
COSCIENS Biopharma’s (CSCI) 10-Day exponential moving average is 4.19, while COSCIENS Biopharma’s (CSCI) share price is $4.145, making it a Buy.
COSCIENS Biopharma’s (CSCI) 100-Day exponential moving average is 5.85, while COSCIENS Biopharma’s (CSCI) share price is $4.145, making it a Sell.
COSCIENS Biopharma’s (CSCI) stock price is $4.145 and COSCIENS Biopharma’s (CSCI) 50-day simple moving average is 5.29, creating a Sell signal.
COSCIENS Biopharma’s (CSCI) stock price is $4.145 and COSCIENS Biopharma’s (CSCI) 100-day simple moving average is 6.22, creating a Sell signal.
COSCIENS Biopharma’s (CSCI) stock price is $4.145 and COSCIENS Biopharma’s (CSCI) 200-day simple moving average is 7.05, creating a Sell signal.

COSCIENS Biopharma (CSCI) Technical Indicators

Sep 20, 2024, 12:19 AM
Name
Value
Implied Action
RSI (14)
41.34
Neutral
STOCH (9,6)
79.53
Neutral
STOCHRSI (14)
79.27
Neutral
MACD (12,26)
-0.37
Sell
ADX (14)
24.00
Neutral
Williams %R
-11.59
Sell
CCI (14)
-21.28
Neutral
ATR (14)
0.34
-
Ultimate Oscillator
52.62
Neutral
ROC
11.61
Buy
COSCIENS Biopharma’s (CSCI) Relative Strength Index (RSI) is 41.34, creating a Neutral signal.
COSCIENS Biopharma’s (CSCI) Trend Strength Indicator (ADX) is 24.00, creating a Neutral signal.
COSCIENS Biopharma’s (CSCI) Commodity Channel Index (CCI) is -21.28, creating a Neutral signal.
COSCIENS Biopharma’s (CSCI) Price Rate of Change (ROC) is 11.61, creating a Buy signal.

FAQ

Is CSCI a Buy, Hold, or Sell?
Based on CSCI’s technical indicators, CSCI is a Sell.
    What is CSCI’s RSI (14)?
    CSCI’s RSI (14) is 41.34, which suggests CSCI is a Neutral.
      What is CSCI’s MACD?
      CSCI’s MACD is -0.37, which suggests CSCI is a Sell.
        What is CSCI’s 5-day moving average?
        CSCI’s 5-day moving average is 4.15, which suggests CSCI is a Buy.
          What is CSCI’s 20-day moving average?
          CSCI 20-day moving average is 4.42, which suggests CSCI is a Sell.
            What is CSCI’s 50-day moving average?
            CSCI’s 50-day moving average is 5.29, which suggests CSCI is a Sell.
              What is CSCI’s 200-day moving average?
              CSCI’s 200-day moving average is 7.05, which suggests CSCI is a Sell.
                What is CSCI’s Williams % R (14)?
                CSCI’s Williams % R (14) is -11.59, which suggests CSCI is a Sell.
                  What is CSCI’s CCI (14)?
                  CSCI’s CCI (14) is -21.28, which suggests CSCI is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis